Clovis Oncology Announces Positive Outcome in European Opposition Proceeding Related to Rubraca® – Business Wire

Spread the love

Clovis Oncology Announces Positive Outcome in European Opposition Proceeding Related to Rubraca® Business Wire

Clovis Oncology, Inc. (NASDAQ:CLVS) announced today after opposition proceedings at The Hague, Netherlands, that the European Patent Office upheld cla.

…read more

Source:: Oakland, California News By Google News

Start a Conversation

[ghozylab-instagram feed=26796]